Lensar LNSR
NASDAQ LNSR
$8.54 -0.18 (-2.06%)
At close: Aug 20, 2026 · 11:16 AM UTC

Lensar (LNSR) Net Income towards Common Stockholders (2019 - 2026)

Lensar (LNSR) posted quarterly Net Income towards Common Stockholders of $18.9 million for Q1 2026, up 169.17% year-over-year from $7.0 million in Q1 2025, and up 1397.26% quarter-over-quarter from -$1.5 million in Q4 2025.

Lensar (LNSR) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends

Lensar (LNSR) has reported Net Income towards Common Stockholders for 8 consecutive years, with $18.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 169.17% year-over-year to $18.9 million; the TTM figure through Mar 2026 stood at $12.0 million (up 121.17% YoY), while the FY2025 annual figure was -$34.3 million, down 9.16% from the prior year.
  • Net Income towards Common Stockholders improved to $18.9 million in Q1 2026 per LNSR's latest filing, from -$1.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $18.9 million in Q1 2026 and bottomed at -$27.3 million in Q1 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$4.8 million across 5 years, with a median of -$3.9 million in 2023.
  • Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders slumped 1167.73% — and 2026, when it surged 169.17%.
  • Lensar's Net Income towards Common Stockholders stood at -$2.5 million in 2022, then slumped by 57.67% to -$3.9 million in 2023, then slumped by 376.36% to -$18.7 million in 2024, then surged by 92.2% to -$1.5 million in 2025, then jumped by 1397.26% to $18.9 million in 2026.
  • Business Quant data shows LNSR's Net Income towards Common Stockholders at $18.9 million in Q1 2026, -$1.5 million in Q4 2025, and -$3.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn 928.00 Mn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn 1.28 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 621.86 Mn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn 201.00 Mn
10 Lensar 105.26 Mn 91.70 Mn 9.78 Mn 2.13 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 114,000.00
Mar 31, 2026 18.91 Mn
Dec 31, 2025 -1.46 Mn
Sep 30, 2025 -3.71 Mn
Jun 30, 2025 -1.76 Mn
Mar 31, 2025 -27.35 Mn
Dec 31, 2024 -18.70 Mn
Sep 30, 2024 -1.50 Mn
Jun 30, 2024 -9.04 Mn
Mar 31, 2024 -2.16 Mn
Dec 31, 2023 -3.93 Mn
Sep 30, 2023 1.43 Mn
Jun 30, 2023 -8.75 Mn
Mar 31, 2023 -4.27 Mn
Dec 31, 2022 -2.49 Mn
Sep 30, 2022 -3.99 Mn
Jun 30, 2022 -6.76 Mn
Mar 31, 2022 -6.67 Mn
Dec 31, 2021 -3.90 Mn
Sep 30, 2021 -6.16 Mn